Who are EV71 Vaccine only's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): fIPV (0.1mL) IM, Vaqta Injectable Product, EV71 +SIV, Sabin IPV, Hepatitis A vaccine, sIPV batch 1.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ev71-vaccine-only.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

EV71 Vaccine only — Competitive Intelligence Brief

EV71 Vaccine only (EV71 Vaccine only) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

marketed Inactivated viral vaccine Enterovirus 71 (EV71) viral antigens Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

EV71 Vaccine only (EV71 Vaccine only) — Sinovac Biotech Co., Ltd. The EV71 vaccine stimulates the immune system to produce antibodies and cellular immunity against Enterovirus 71, preventing infection and disease.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
EV71 Vaccine only TARGET	EV71 Vaccine only	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens
fIPV (0.1mL) IM	fIPV (0.1mL) IM	Centers for Disease Control and Prevention	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
Vaqta Injectable Product	Vaqta Injectable Product	National Taiwan University Hospital	marketed	Inactivated viral vaccine	Hepatitis A virus surface antigen
EV71 +SIV	EV71 +SIV	Zhejiang Provincial Center for Disease Control and Prevention	marketed	Inactivated viral vaccine
Sabin IPV	Sabin IPV	Centers for Disease Control and Prevention, China	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
Hepatitis A vaccine	Hepatitis A vaccine	MacroGenics	marketed	inactivated viral vaccine	Hepatitis A virus surface antigens
sIPV batch 1	sIPV batch 1	Institute of Medical Biology, Chinese Academy of Medical Sciences	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

Sinovac Biotech Co., Ltd · 9 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
GlaxoSmithKline · 5 drugs in this class
Valneva Austria GmbH · 4 drugs in this class
Medical University of Vienna · 3 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
China National Biotec Group Company Limited · 2 drugs in this class
Statens Serum Institut · 2 drugs in this class
Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). EV71 Vaccine only — Competitive Intelligence Brief. https://druglandscape.com/ci/ev71-vaccine-only. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab